FUCHS SE/ DE000A3E5D64 /
2024-12-20 5:36:15 PM | Chg. +0.14 | Volume | Bid5:36:15 PM | Ask5:36:15 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
41.32EUR | +0.34% | 42,995 Turnover: 949,017.47 |
-Bid Size: - | -Ask Size: - | 4.86 bill.EUR | 2.66% | 20.04 |
GlobeNewswire
08-05
Design Therapeutics Announces Second Quarter 2024 Financial Results and Reviews Near-term Milestones...
GlobeNewswire
07-24
The ADVERTISING Club of New York Taps Power Players to Join the Board of Directors; Naming Five New ...
GlobeNewswire
07-24
OTC Markets Group Announces Real-Time Data Distribution with uSMART Securities Out of Hong Kong
GlobeNewswire
07-04
CSL Behring Announces First Two Patients Treated with HEMGENIX® (etranacogene dezaparvovec) Gene The...
GlobeNewswire
05-09
Surrozen Presents Data Demonstrating the Promise of Antibody-Based Wnt Mimetics in Treating Cornea E...
GlobeNewswire
05-08
Design Therapeutics Announces First Quarter 2024 Financial Results and Highlights Upcoming Program M...
GlobeNewswire
05-07
Design Therapeutics to Participate in the 2024 RBC Capital Markets Global Healthcare Conference
GlobeNewswire
05-02
insightsoftware Recognized as DACH Region Market Leader for Sixth Consecutive Year in BARC Score Fin...
GlobeNewswire
04-10
BPM Partners and BARC Join Forces to Deliver First of Its Kind Global CPM Priorities and Trends Rese...
GlobeNewswire
03-19
Design Therapeutics Outlines Progress Across GeneTAC™ Platform and Announces Fourth Quarter and Full...
GlobeNewswire
03-12
Design Therapeutics to Webcast Fourth Quarter and Full Year 2023 Financial Results and Comprehensive...
GlobeNewswire
03-07
American Institutes for Research Education Experts to Present at the Council for Exceptional Childre...
GlobeNewswire
01-30
PolTREG CEO Trzonkowski co-authors peer-reviewed article showing scientific progress in T-reg autoim...
GlobeNewswire
01-24
Fordham University Gabelli School of Business Global Healthcare Innovation Management Center to Host...
GlobeNewswire
2023-12-09
Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 an...
GlobeNewswire
2023-11-13
Design Therapeutics Reports Third Quarter 2023 Financial Results and Plans for a Comprehensive Portf...